Growing significance of myeloperoxidase in non-infectious diseases

Clinical Chemistry and Laboratory Medicine : CCLM
A HoyS Visvikis

Abstract

Myeloperoxidase (MPO) is a glycoprotein released by activated polymorphonuclear neutrophils, which takes part in the defense of the organism through production of hypochlorous acid (HOCl), a potent oxidant. Since the discovery of MPO deficiency, initially regarded as rare and restricted to patients suffering from severe infections, MPO has attracted clinical attention. The development of new technologies allowing screening for this defect has permitted new advances in the comprehension of underlying mechanisms. Apart from its implications for host defense, the expression of MPO restricted to myeloid precursors makes MPO mRNA a good marker of acute myeloid leukemia. In addition, during the last few years, involvement of MPO has been described in numerous diseases such as atherosclerosis, lung cancer, Alzheimer's disease and multiple sclerosis. Both strong oxidative activity and MPO genetic polymorphism have been involved. This review summarizes the broad range of diseases involving MPO and points out the possible use of this protein as a new clinical marker and a future therapeutic target.

References

Jan 1, 1991·Free Radical Biology & Medicine·M A Trush, T W Kensler
Oct 1, 1970·The Journal of Experimental Medicine·R van FurthM E Fedorko
May 1, 1983·The Journal of Clinical Investigation·W M NauseefH L Malech
Sep 1, 1981·Annals of Internal Medicine·M F ParryW J Richar
Jul 1, 1994·The Journal of Clinical Investigation·A DaughertyJ W Heinecke
Mar 15, 1996·The Journal of Clinical Investigation·L J HazellR Stocker
Oct 23, 1997·Journal of Neuroimmunology·R M NagraW F Reynolds
Oct 23, 1997·Current Opinion in Lipidology·J W Heinecke
Jun 17, 1998·Free Radical Biology & Medicine·A JerlichR J Schaur
Jun 24, 1998·The Journal of Clinical Investigation·F R DeLeoW M Nauseef
Oct 10, 1998·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·W M Nauseef
Oct 10, 1998·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·F Lanza
Oct 10, 1998·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·C G Kallenberg
Oct 16, 1999·Proceedings of the Association of American Physicians·S J Klebanoff
Feb 3, 2000·Free Radical Biology & Medicine·C JolivaltG Siest
Apr 1, 2000·Journal of Neuroimmunology·O H KantarciB G Weinshenker
Jun 3, 2000·Carcinogenesis·M B SchabathX Wu
Feb 22, 2001·The Journal of Clinical Investigation·M L BrennanA J Lusis
May 30, 2001·Japanese Journal of Cancer Research : Gann·N HamajimaS Tominaga

❮ Previous
Next ❯

Citations

Aug 30, 2003·Neuroscience Letters·Brigitte Leininger-MullerSophie Visvikis
Dec 9, 2009·Journal of the American Chemical Society·Elisenda RodríguezJohn W Chen
Nov 18, 2008·Proceedings of the National Academy of Sciences of the United States of America·Michael O BreckwoldtRalph Weissleder
Jul 25, 2012·Antioxidants & Redox Signaling·Claudia NussbaumMarkus Sperandio
Jul 14, 2010·Bioscience, Biotechnology, and Biochemistry·Hiroyuki FukamiYasukazu Tanaka
Feb 5, 2014·Biochemistry. Biokhimii︠a︡·O M PanasenkoA V Sokolov
May 14, 2014·Cancers·Amy L RymaszewskiHaris G Vikis
Jun 28, 2011·Lasers in Medical Science·Adenilson de Souza da FonsecaSamuel Santos Valença
Dec 22, 2004·Kidney International·Bertrand L JaberVaidyanathapuram S Balakrishnan
Apr 16, 2003·Kidney International. Supplement·Roberto Pecoits-FilhoLouise Nordfors
Oct 25, 2011·Veterinary Immunology and Immunopathology·Jella WautersEvelyne Meyer
Jun 6, 2009·Ageing Research Reviews·Davide SeripaAlberto Pilotto
Sep 16, 2008·Seminars in Nephrology·Orfeas Liangos, Bertrand L Jaber
Jul 31, 2007·Pharmacology & Therapeutics·Corinne M Spickett
Nov 28, 2006·The American Journal of Cardiology·Sotirios Tsimikas
Mar 30, 2005·Biochemical Pharmacology·Walter JantschkoChristian Obinger
Mar 19, 2014·Free Radical Biology & Medicine·Benjamin S RaynerClare L Hawkins
Feb 16, 2010·Toxicology·Agnieszka RobaszkiewiczMirosław Soszyński
Jul 26, 2013·Journal of Lipid Research·Hao ZhangKirkwood A Pritchard
Jan 4, 2018·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Michael John PeckRolf Weitkunat
May 11, 2018·Free Radical Research·Giancarlo AldiniFrancesco Sergio
Feb 4, 2005·Journal of Leukocyte Biology·Seymour J Klebanoff
Jun 1, 2011·Molecular Informatics·Alberto MalvezziAntonia T-do Amaral
Jul 26, 2003·The Journal of Parasitology·Michael HurtHassan Alizadeh
Jul 18, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Jian YangChunxiang Zhang
Jul 30, 2011·Chemical Communications : Chem Comm·Corin StorkeyCarl H Schiesser
Aug 16, 2011·The Journal of Pharmacology and Experimental Therapeutics·Brankica PaunovicZsuzsanna Sandor
Feb 11, 2020·Food & Function·Premkumar JayarajRajagopal Desikan
Jan 29, 2020·Antioxidants & Redox Signaling·Michael J Davies, Clare L Hawkins
Jan 23, 2021·International Journal of Molecular Sciences·Marta GueriniPaola Perugini
Sep 16, 2018·The Journal of Nutritional Biochemistry·Xia XiaoMatam Vijay-Kumar
Jun 24, 2003·Journal of the American Society of Nephrology : JASN·Peter StenvinkelBengt Lindholm
Aug 28, 2021·Antioxidants·Maria Nunzia De LucaVittorio Unfer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.